Expression changes of CYP2A and CYP3A in microsomes from pig liver and cultured hepatocytes

Pharmacology and Toxicology

Volumn 87, Issue 4, 2000, Pages 174-178

  Skaanild, Mette T ^a   Friis, Christian ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

APOPROTEIN; CYTOCHROME P450 2A; CYTOCHROME P450 3A; GROWTH HORMONE; PYRAZOLE; RIFAMPICIN; TESTOSTERONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME STABILITY; FEMALE; FETAL CALF SERUM; IMMUNOBLOTTING; IN VITRO STUDY; LIVER CELL CULTURE; LIVER MICROSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE; TOXICITY TESTING;

ANIMALIA; STAPHYLOCOCCUS PHAGE 3A; SUS SCROFA;

EID: 0033790825     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2000.d01-69.x     Document Type: Article

References (21)

1. George, J., B. Goodwin, C. Liddle, M. Tapner & G. C. Farrell: Time-dependent expression of cytochrome P450 genes in primary cultures of well-differentiated human hepatocytes. J. Lab. Clin. Med. 1997, 129, 638-647.
2. Kojo, A., P. Viitala, M. Pasanen, O. Pelkonen, H. Raunio & R. Juvonen: Induction of CYP2A5 by pyrazole and its derivates in mouse primary hepatocytes. Arch. Toxicol. 1998, 72, 336-341.
3. Li, A. P., A. Rasmussen, L. Xu & D. L. Kaminski: Rifampicin induction of lidocaine metabolism in cultures human hepatocytes. J. Pharmacol. Exp. Therap. 1995, 274, 673-677.
4. Li, A. P., M. K. Reith, A. Rasmussen, J. C. Gorski, S. D. Hall, L. Xu, D. L. Kaminski & L. K. Cheng: Primary human hepatocytes as a tool for the evaluation of structure-activity relationship in cytochrome P450 induction potential of xenobiotics: evaluation of rifampicin, rifapentine and rifabutin. Chemical. Biol. Interact. 1997, 107, 17-30.
5. Liddle, C., A. Mode, C. Legraverend & J.-Å. Gustafson: Constitutive expression and hormonal regulation of male sexually differentiated cytochromes P450 in primary cultured rat hepatocytes. Arch. Biochem. Biophys. 1992, 298, 159-166.
6. Liddle, C., B. J. Goodwin, J. Tapner & C. C. Farrell: Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes. J. Clin. Endocrin. Metab. 1998, 83, 2411-2416.
7. Massa, G., N. Mulumba, J. M. Ketelslegers & M. Maes: Initial characterization and sexual dimorphism of serum growth-binding protein in adult rats. Endocrinology 1990, 126, 1976-1980.
8. Massa, G., L. Dooms, R. Bouillon & M. Vanderschueren-Lodeweyckx: Serum levels of growth hormone-binding protein and insulin-like growth factor I in children and adolescent with type I (insulin-dependent) diabetes mellitus. Diabetologia 1993, 36, 239-243.
9. Mattes, W. B. & A. P. Li: Quantitative reverse transcription/PCR assay for the measurement of induction in cultured hepatocytes. Chem. Biol. Interact. 1997, 107, 47-61.
10. Miquet, J. P., P. Maview, C. J. Soussy & D. Dhumeaux: Induction of hepatic microsomal enzymes after brief administration of rifampicin in man. Gastroenterol. 1977, 72, 924-926.
11. Monshouwer, M., G. A. E. van't Klooster, S. M. Nijmeijeer, R. F. Witkamp & A. S. J. A. M. vaan Miert: Characterization of cytochrome P450 isoenzymes in primary cultures of pig hepatocytes. Toxicol. in vitro 1998, 12, 715-723.
12. Nelson, D. R., L. Koymans, T. Kamati, J. J. Stegeman, R. Feyereisen, D. J. Waxman, M. R. Waterman, O. Gotoh, M. J. Coon, R. W. Estabrook, I. C. Gunsalus & D. W. Nebert: P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996, 6, 1-42.
13. Olsen, A. K., K. T. Hansen & C. Friis: Pig hepatocytes as an in vitro model to study the regulation of human CYP3A4: prediction of drug-drug interaction with 17 alfa-ethynylestradiol. Chem. Biol. Interact. 1997, 107, 93-108.
14. Pampori, N. A. & B. H. Shapiro: Gender differences in the responsiveness of the sex-dependent isoforms of hepatic P450 to feminine plasma growth hormone profile. Endocrinology 1999, 140, 1245-1254.
15. Ratanasavahn, D., D. Lamiable, M. Biour, Y. Guedes, M. Gersberg, E. Leutenegger & C. Riche: Metabolism and toxicity of coumarin on cultured human, rat, mouse and rabbit hepatocytes. Fund. Clin. Pharmacol. 1996, 10, 504-510.
16. Salonpää, P., K. Krause, O. Pelkonen & H. Raunio: Up-regulation of CYP2A5 expression by phorphyrinogenic agents in mouse liver. Naunyn-Schmiedeberg's Arch. Pharmacol. 1995, 351, 446-452.
17. Shimada, M., N. Murayama, K. Nagata, H. Hashimoto, H. Ishikawa & Y. Yamazoe: A specific loss of growth hormone abolished sex-dependent expression of hepatic cytochrome P450 in dwarf rats: reversal of the profile by growth hormone-treatment. Arch. Biochem. Biophys. 1997, 337, 34-42.
18. Skaanild, M. T. & C. Friis: Characterization of the P450 system in Göttingen minipig. Pharmacology & Toxicology 1997, 80 suppl. II, 28-33.
19. Skaanild, M. T. & C. Friis: Cytochrome P450 sex differences in minipigs and conventional pigs. Pharmacology & Toxicology 1999, 85, 174-180.
20. Tobar-Dupres, E. T., D. P. Froman & S. L. Davis: Factors affecting circulating growth hormone binding protein in chickens. Poult. Sci. 1993, 72, 2337-2346.
21. Vandenbranden, M., S. A. Wrighton, S. Ekins, J. S. Gillespie, S. N. Binkley, B. J. Ring, M. G. Gadberry, D. C. Mullins, S. C. Strom & C. B. Jensen: Alterations of the catalytic activities of drug-metabolizing enzymes in cultures of human liver slices. Drug Metab. Disp. 1998, 26, 1063-1068.